you are here: Home News Strides Shasun

Strides Shasun

Buy Strides Shasun; target of Rs 481: Motilal Oswal
Buy Strides Shasun; target of Rs 480: HDFC Securities
Market nervous ahead of Q1 earnings; 3 stocks that could offer 7-13% return
Strides Shasun stock gains 2% on USFDA approval for painkiller drug
Strides Shasun gets WHO pre-qualification for its rectal artesunate product
Strides Shasun seeks shareholders' nod to change name to Strides Pharma Science
Buy Strides Shasun; target of Rs 530: JM Financial
Buy Strides Shasun; target of Rs 980: HDFC Securities
Market Update: GMR Infra, Voltas drag Midcap index down; Strides Shasun plunges 20%
Strides Shasun Q4 consolidated loss from continuing operations at Rs 4.4 cr
Strides Shasun plunges 23% after consolidated loss from continuing operations in Q4
Strides Shasun to divest API arm to Solara for Rs 131 cr
Strides Shasun gains 2% on USFDA approval for antihistamine drug
Strides Shasun likely to test Rs 788 in 9-12 months: Akash Jain
Strides Shasun gets USFDA nod for generic Ibuprofen capsules
Nifty likely to face stiff resistance at 10,490; top 5 stocks which can give up to 5% return in short term
Strides Shasun gets USFDA nod for HIV treatment drug
Strides Shasun to launch Ranitidine tablets in US
Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for February 22
Strides Shasun arm gets USFDA nod for HIV drug
Top 12 stocks which gave multibagger returns as Nifty rose from 10,000 to 11,000
Buy Reliance Industries, Torrent Power, Strides Shasun; sell Union Bank of India: Sudarshan Sukhani
Strides Shasun buys controlling stake in South African drug co Trinity Pharma for Rs 27.5 cr
Strides acquires controlling stake in South Africa's Trinity
Buy Strides Shasun; target of Rs 1200: HDFC Securities

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Strides Shasun

Buy Strides Shasun; target of Rs 481: Motilal Oswal

Buy Strides Shasun; target of Rs 480: HDFC Securities

Market nervous ahead of Q1 earnings; 3 stocks that could offer 7-13% return

Strides Shasun stock gains 2% on USFDA approval for painkiller drug

Strides Shasun gets WHO pre-qualification for its rectal artesunate product

Strides Shasun seeks shareholders' nod to change name to Strides Pharma Science

Buy Strides Shasun; target of Rs 530: JM Financial

Buy Strides Shasun; target of Rs 980: HDFC Securities

Market Update: GMR Infra, Voltas drag Midcap index down; Strides Shasun plunges 20%

Strides Shasun Q4 consolidated loss from continuing operations at Rs 4.4 cr

Strides Shasun plunges 23% after consolidated loss from continuing operations in Q4

Strides Shasun to divest API arm to Solara for Rs 131 cr

Strides Shasun gains 2% on USFDA approval for antihistamine drug

Strides Shasun likely to test Rs 788 in 9-12 months: Akash Jain

Strides Shasun gets USFDA nod for generic Ibuprofen capsules

Nifty likely to face stiff resistance at 10,490; top 5 stocks which can give up to 5% return in short term

Strides Shasun gets USFDA nod for HIV treatment drug

Strides Shasun to launch Ranitidine tablets in US

Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for February 22

Strides Shasun arm gets USFDA nod for HIV drug

Top 12 stocks which gave multibagger returns as Nifty rose from 10,000 to 11,000

Buy Reliance Industries, Torrent Power, Strides Shasun; sell Union Bank of India: Sudarshan Sukhani

Strides Shasun buys controlling stake in South African drug co Trinity Pharma for Rs 27.5 cr

Strides acquires controlling stake in South Africa's Trinity

Buy Strides Shasun; target of Rs 1200: HDFC Securities